Guidelines for ATC classification and DDD assignment - WHOCC

N06AF Monoamine oxidase inhibitors, non-selective
N06AG Monoamine oxidase A inhibitors
N06AX Other antidepressants
This group includes antidepressants, which cannot be classified in the
preceding groups.
N06B PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND
NOOTROPICS
Nootropics are classified in N06BX.
N06BA Centrally acting sympathomimetics
Amfetamine is classified in this group, see comment under A08AA -
Centrally acting antiobesity products.
Since atomoxetine is approved for use both in children, adolescents
and in adults, the DDD is based on the treatment of a 70 kg person.
The majority of the users will, however, probably be under 18 years
of age.
N06BC Xanthine derivatives
Caffeine in combination with respiratory stimulants is classified in
R07AB.
N06BX Other psychostimulants and nootropics
This group comprises substances regarded as nootropics.
Psychostimulants, which cannot be classified in the preceding groups,
are also classified here.
Cyprodenate (deanol cyclohexylpropionate) is classified in N06BX04.
221